Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Gastroenterología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 4
ClinicalTrials.gov
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
INTERVENTIONAL
Inicio: 26 de dic de 2014
ID: NCT02308111
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, 5 Treatment Arms, 4-period, Incomplete Cross-over Study to Determine the Effect of 6 Weeks Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (FDC) (2.5 / 5 µg; and 5 / 5 µg) (Delivered by the Respimat® Inhaler) Compared With Tiotropium (5 µg), Olodaterol (5 µg ) and Placebo (Delivered by the Respimat® Inhaler) on Lung Hyperinflation and Exercise Endurance Time During Constant Work Rate Cycle Ergometry in Patients With Chronic Obstructive Pulmonary Disease (COPD) [MORACTO TM 2]
INTERVENTIONAL
Inicio: 1 de feb de 2012
ID: NCT01533935
Terminado
Fase 2
ClinicalTrials.gov
A Phase 1b/2 Study of Derazantinib as Monotherapy and Combination Therapy With Paclitaxel, Ramucirumab or Atezolizumab in Patients With HER2-negative Gastric Adenocarcinoma Expressing FGFR2 Genetic Aberrations
INTERVENTIONAL
Inicio: 6 de oct de 2020
ID: NCT04604132
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, 2-Arm Randomized, Open-Label Study of Trastuzumab Deruxtecan in Subjects With HER2-Positive Metastatic and/or Unresectable Gastric or Gastro-Esophageal Junction (GEJ) Adenocarcinoma Subjects Who Have Progressed on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)
INTERVENTIONAL
Inicio: 21 de may de 2021
ID: NCT04704934
Completado
Fase 2
ClinicalTrials.gov
A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Trial of Multiple Sublingual 5-MeO-DMT Microdoses for Reducing Anxiety and/or Depression in Patients With Mild Cognitive Impairment.
INTERVENTIONAL
Inicio: 15 de dic de 2024
ID: NCT06812221
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Multi-center Phase III Study of Brivanib Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Subjects With Advanced Hepatocellular Carcinoma (HCC) Who Have Failed or Are Intolerant to Sorafenib: The BRISK PS Study (Brivanib Study in HCC Patients at Risk Post Sorafenib)
INTERVENTIONAL
Inicio: 17 de feb de 2009
ID: NCT00825955
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy
INTERVENTIONAL
Inicio: 1 de nov de 2011
ID: NCT01494506
Terminado
Fase 2
ClinicalTrials.gov
Evaluation of Belatacept as First Line Immunosuppression in De Novo Liver Transplant Recipients
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00555321
Completado
Fase 4
ClinicalTrials.gov
Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in Children
INTERVENTIONAL
Inicio: 19 de jun de 2017
ID: NCT03539913
Desconocido
ClinicalTrials.gov
A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate
EXPANDED_ACCESS
Inicio: 1 de sept de 2004
ID: NCT00094029
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arterial Hypertension (PAH)
INTERVENTIONAL
Inicio: 3 de sept de 2024
ID: NCT06274801
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
INTERVENTIONAL
Inicio: 10 de oct de 2022
ID: NCT05507203
Desconocido
ClinicalTrials.gov
Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy in a High-volume Center. A Cohort Study.
OBSERVATIONAL
Inicio: 1 de oct de 2015
ID: NCT02597218
Reclutando
ClinicalTrials.gov
Pivotal Study to Evaluate the Safety and Effectiveness of the CereVasc® eShunt® System in the Treatment of Normal Pressure Hydrocephalus
INTERVENTIONAL
Inicio: 26 de nov de 2024
ID: NCT06498960
Completado
ClinicalTrials.gov
A Cross-sectional, Multi-center, Epidemiological Study in Western and Asian Countries in Children and Adolescents With Chronic Hepatitis B
OBSERVATIONAL
Inicio: 1 de jun de 2009
ID: NCT01163240
Terminado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of 12 Months of Therapy With Inhaled Colistimethate Sodium in Subjects With Non-cystic Fibrosis Bronchiectasis Chronically Infected With P. Aeruginosa
INTERVENTIONAL
Inicio: 29 de ene de 2018
ID: NCT03460704
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study of the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease
INTERVENTIONAL
Inicio: 10 de may de 2017
ID: NCT03105128
Reclutando
Fase 3
ClinicalTrials.gov
A 4-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Fluticasone Propionate/Albuterol Sulfate Combination Compared to Fluticasone Propionate, Albuterol Sulfate or Placebo Delivered by Multidose Dry Powder Inhaler in Participants 12 Years and Older With Asthma
INTERVENTIONAL
Inicio: 12 de dic de 2024
ID: NCT06664619
Aún no recluta
ClinicalTrials.gov
Clinical Evaluation of Safety and Effectiveness of the Munich Transcatheter Mitral Valve Replacement (TMVR) System
INTERVENTIONAL
Inicio: 30 de jul de 2023
ID: NCT05871983
Completado
Fase 2
ClinicalTrials.gov
A Randomized Controlled Study of BAY43-9006 in Combination With Doxorubicin Versus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma.
INTERVENTIONAL
Inicio: 1 de abr de 2005
ID: NCT00108953
Anterior
1
...
18
19
20
...
434
Siguiente
Filtros